Training Activity References
Accord Healthcare, Inc.. Naltrexone Hydrochloride – drug label information. Dailymed. 2014. Available at: http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=49aa3d6d-2270-4615-aafa-b440859ab870 Accessed on: 2015-06-11.
AHRQ. Clinician Summary – Pharmacotherapy for Adults With Alcohol Use Disorder (AUD) in Outpatient Settings. AHRQ.gov. 2016. Available at: https://www.effectivehealthcare.ahrq.gov/ehc/products/477/2161/alcohol-misuse-drug-therapy-clinician-160211.pdf Accessed on: 2016-02-25.
Alkermes, Inc.. Vivitrol – drug label information. Dailymed. 2013. Available at: http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cd11c435-b0f0-4bb9-ae78-60f101f3703f#section-2.4 Accessed on: 2015-06-11.
Gastfriend D. Intramuscular extended-release naltrexone: current evidence. Annals of the New York Academy of Sciences. 2011; 1216: 144-166. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21272018 Accessed on: 2015-06-11.
Heilig M, Goldman D, Berrettini W, O’Brien CP. Pharmacogenetic approaches to the treatment of alcohol addiction. Nature Reviews Neuroscience. 2011; 12: 670-684. Available at: http://www.nature.com/nrn/journal/v12/n11/full/nrn3110.html Accessed on: 2015-05-29.
Iheanacho T, Issa M, Marienfeld C, et al. Use of naltrexone for alcohol use disorders in the Veterans’ Health Administration: A national study. Drug and Alcohol Dependence. 2013; 132: 122-123. Available at: http://www.ncbi.nlm.nih.gov/pubmed/23434041 Accessed on: 2015-06-10.
Kalra G, De Sousa A, Shrivastava A. Disulfiram in the management of alcohol dependence: A comprehensive clinical review. OJPsych. 2014; 4: . Available at: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=41667#.VWXQE8_BzRY Accessed on: 2015-05-27.
Lee J, Kresina TF, Campopiano M, et al.. Use of Pharmacotherapies in the Treatment of Alcohol Use Disorders and Opioid Dependence in Primary Care. Biomed Research International. 2015. Available at: http://www.ncbi.nlm.nih.gov/pubmed/25629034 Accessed on: 2015-06-09.
Mason BJ, Lehert P. Acamprosate for Alcohol Dependence: A Sex-Specific Meta-Analysis Based on Individual Patient Data. Alcoholism: Clinical and Experimental Research. 2012; 36(3): 497-508. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21895717 Accessed on: 2015-06-09.
Mylan Pharmaceuticals Inc.. Acamprosate Calcium tablet, delayed release Drug Label Information. Dailymed. 2014. Available at: http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=75ddfd10-55b2-426e-bc74-3413cd0d7c94 Accessed on: 2015-06-09.
NIAAA. Treatment for alcohol problems: Finding and getting help. NIH. 2014. Available at: http://pubs.niaaa.nih.gov/publications/Treatment/treatment.htm Accessed on: 2015-05-20.
Physicians Total Care Inc. Antabuse – Disulfiram tablet. DailyMed. 2012. Available at: http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=12850de3-c97c-42c1-b8d3-55dc6fd05750 Accessed on: 2015-06-10.
Reus VI, Fochtmann LJ, Buckstein O, et al.. The American Psychiatric Association practice guideline for the pharmacological treatment of patients With Alcohol Use Disorder. The American Journal of Psychiatry. 2018; 175(1): 86-90. Available at: https://ajp.psychiatryonline.org/doi/abs/10.1176/appi.ajp.2017.1750101?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed& Accessed on: 2018-01-13.
SAMHSA. Screening, Brief Intervention, and Referral to Treatment (SBIRT). SAMHSA. 2014. Available at: http://www.samhsa.gov/sbirt Accessed on: 2015-03-20.
SAMHSA. The facts about naltrexone. HHS Publication No. (SMA) 12-4444. 2012. Available at: http://store.samhsa.gov/product/The-Facts-about-Naltrexone-for-Treatment-of-Opioid-Addiction/SMA15-4444 Accessed on: 2015-06-11.
Skinner MD, Lahmek P, Pham H, Aubin HJ. Disulfiram efficacy in the treatment of alcohol dependence: A meta-analysis. PLoS One. 2014; 9: . Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919718/ Accessed on: 2015-05-28.
Specka M, Heilmann M, Lieb B, Scherbaum N. Use of disulfiram for alcohol relapse prevention in patients in opioid maintenance treatment. Clin Neuropharmacol. 2014; 37: 161-165. Available at: http://www.ncbi.nlm.nih.gov/pubmed/25384073 Accessed on: 2015-05-28.
Swift RM, Aston ER. Pharmacotherapy for alcohol use disorder: Current and emerging therapies. Harv Rev Psychiatry. 2015; 23: 122-133. Available at: http://www.ncbi.nlm.nih.gov/pubmed/25747925 Accessed on: 2015-05-29.
VA/DoD. VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders. . 2015. Available at: http://www.healthquality.va.gov/guidelines/MH/sud/ Accessed on: 2016-11-15.
Yahn SL, Watterson LR, Olive MF. Safety and efficacy of acamprosate for the treatment of alcohol dependence. Subst Abuse. 2013; 6: 1-12. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565569/ Accessed on: 2015-05-28.
